Practical PCNL: From Access to Exit - A Hands-On Course - California (2018)

February 24, 2018 to February 25, 2018

Because of the relative paucity of PCNL cases in training programs which are not high-volume centers, many residents do not gain enough practical experience to feel comfortable with obtaining percutaneous access and performing PCNL. Concerns over morbidity of the operation due to a lack of familiarity and ability to troubleshoot challenges or complications may lead surgeons to avoiding PCNL when it is the ideal surgical approach to a stone. Making the “rare” case into a “routine” one by enabling hands-on experience in all phases of the surgery will address the gap in practice, allowing more urologists to offer PCNL to their patients.

Target Audience

  • Resident
  • Urologist

Learning Objectives

After attending this course, participants will be able to: 

  1. Obtain percutaneous access to the kidney using fluoroscopy in combination with ureteroscopic and/or ultrasound guidance.
  2. Perform prone flexible cystoscopy.
  3. Demonstrate the optimal methods for post-operative sealing or drainage of the percutaneous tract.
  4. Utilize flexible ureteroscopy and instrumentation in combination with PCNL to enhance renal access and stone treatment success.
  5. Routinely employ a ureteral access sheath during flexible ureteroscopy.
  6. Perform and review ultrasound imaging.
  7. Recognize and manage complications of PCNL.
  8. Apply knowledge gained in this course to develop a practice in which PCNL becomes an integral surgical procedure in the treatment of stone disease.
Course summary
Available credit: 
  • 13.00 AMA PRA Category 1 Credit™
  • 13.00 Non-Physician Participation
Course opens: 
02/24/2018
Course expires: 
02/25/2021
Event starts: 
02/24/2018 - 7:00am
Event ends: 
02/25/2018 - 12:00pm
Price:
$1,875.00
Rating: 
0

Saturday, February 24, 2018

7:00 – 7:05 a.m

Welcome

Ralph V. Clayman, MD and Jamie Landman, MD

7:05 – 7:15 a.m.

Pre-test

Ralph V. Clayman, MD and Jamie Landman, MD

7:15 – 7:30 am

Pre-procedural Planning and 3D CT Imaging

Ben H. Chew, MD, MSc, FRCSC

7:30 – 7:50 am 

Renal Anatomy for Percutaneous Stone Removal

7:50 – 8:05 am

Patient Preparation: Prep, Drape, and Positioning (Prone, Supine, and   Lateral)

Matthew D. Dunn, MD

8:05 – 8:25 am

Fundamentals of Fluoroscopy and Radiation Safety

Duane D. Baldwin, MD

8:25 – 8:40 am 

Fluoroscopy Guided Percutaneous Access: “Bull’s Eye” and “Drift   Down”

Jamie Landman, MD

8:40 – 9:00 am

Fundamentals of Renal Ultrasound

Chandana Lall, MD

Break

9:15 – 9:35 am                 

Ultrasound-guided Percutaneous Access

Thomas Chi, MD

9:35 – 9:50 am 

Endoscopic-guided Percutaneous Access: Prone Cystoscopy/Ureteral Access Sheath

Roshan M. Patel, MD

9:50 - 10:05am                  

Inside-Out Access: Endoscopic guided Lawson Rocket Wire

Kamaljot Kaler, MD, FRCSC

10:05 – 10:25 am

Dilation of the Nephrostomy Tract: Technique and Avoidance of Complications

Thomas Chi, MD

Break

10:45 – 11:05 am

Lithotripsy: Pneumatic, Ultrasound and Laser

Jamie Landman, MD

11:05 – 11:15 am

Stone Fragment Evacuation: Instrumentation and MIP

Roshan M. Patel, MD

11:15 – 11:25 am

Flexible Nephroscopy: Tips and Tricks

Ben H. Chew, MD, MSc, FRCSC

11:25 – 11:45 am

Ending the Procedure: Tube and Tubeless Techniques

Matthew D. Dunn, MD

11:45 am – 12:15 pm

Better than Live: Putting it All Together (Video Session)

Ralph V. Clayman, MD

Lunch

1:00 – 5:15 pm

Surgical Skills Lab

Sunday, February 25, 2018

8:00 - 8:30 am       

Challenges of PCNL: Tips and Tricks (Horseshoe Kidney, Calyceal Diverticulum, Pelvic Kidney, Spinal Abnormalities)

Matthew D. Dunn, MD

8:30 – 9:00 am                           

PCNL: Complications of PCNL/URS: Prevention, Recognition, and Resolution

Thomas Chi, MD              

9:00 – 9:20 am 

Follow-up: Imaging, Laboratory Studies, Postoperative Visits, Quality of Life Issues and Management of Stent Pain

Ramy F. Youseef-Yaacoub, MD

9:20 - 9:50 am                  

Medical Management of Kidney Stones: Stone: Trees

Ralph V. Clayman, MD

Break

10:10 – 10:30 am               

Billing in the Age of ICD-10

Michael A. Ferragamo, MD, FACS

10:30 – 11:10 am               

Panel Session: PCNL Cases (Instructive and Problematic)

Moderator: Jaime Landman
Panel: Thomas, Chi, MD; Duane D. Baldwin, MD; Ben H. Chew, MD, MSc, FRCSC; Matthew D. Dunn, MD; and Ramy F. Youseef-Yaacoub, MD

11:10 – 11:40 am               

PCNL Start to Finish: Rapid Fire Review and Questions: What’s the Next Step

Ralph V. Clayman, MD

11:40 am – 12:00 pm               

Post-test/Questions      

Ralph V. Clayman, MD and Jamie Landman, MD

Adjourn

University of California- Irvine
Irvine, CA
United States

Name

Company

Role

Financial

Duane D. Baldwin, MD

Cook Urological, Inc.

Meeting Participant or Lecturer

Yes

Olympus Corporation

Consultant or Advisor

Yes

Bard Medical Division

Consultant or Advisor

Yes

DARRT

Leadership Position

Yes

StepLite

Leadership Position

Yes

Pfizer

Investment Interest

Yes

Ben H. Chew, MD, MSc, FRCSC

Boston Scientific Corporation

Consultant or Advisor

Yes

Cook Urological

Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial

No

Olympus-ACMI

Consultant or Advisor

Yes

ADVA- Tec

Consultant or Advisor, Scientific Study or Trial

Yes

Urotech

Consultant or Advisor

Yes

Bard Medical

Consultant or Advisor, Meeting Participant or Lecturer

Yes

Auris Surgical Robotics

Consultant or Advisor, Scientific Study or Trial, Investment Interest

Yes

Thomas Chi , MD

Bard

Meeting Participant or Lecturer

Yes

Boston Scientific Corporation

Consultant or Advisor

Yes

Auris

Consultant or Advisor

No

Ralph V. Clayman, MD

Applied Urology

Investment Interest

Yes

MizuhOSI

Other

Yes

Cook Urological

Other

Yes

Auris Inc.

Consultant or Advisor, Scientific Study or Trial

Yes

Karl Storz, Inc

Scientific Study or Trial

Yes

Matthew D. Dunn, MD

Boston Scientific

Consultant or Advisor, Scientific Study or Trial

Yes

Michael A. Ferragamo, MD, FACS

Nothing to disclose

Kamaljot Kaler, MD, FRCSC

Cook Medical

Meeting Participant or Lecturer

Yes

Karl Storz

Scientific Study or Trial

Yes

Minimally Invasive Force Sensor and Monitoring System

Owner, Product Development

Yes

Chandana Lall, MD

Nothing to disclose.

Jaime Landman, MD

Cook Urological

Consultant or Advisor, Owner, Product Development

No

Galil Medical

Consultant or Advisor

Yes

CONMED

Consultant or Advisor

Yes

Auris

Consultant or Advisor, Investment Interest

Yes

Allergan

Scientific Study or Trial

Yes

Zhamshid H. Okhunov, MD

Nothing to disclose.

Roshan M. Patel, MD

Nothing to disclose.

Ramy F. Youssef-Yaacoub,MD

Nothing to disclose.

Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation:

  • Full Course: The American Urological Association designates this live activity and enduring material for a maximum of 13.00 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
  • Didactic Only: The American Urological Association designates this live activity for a maximum of 9.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

Evidence Based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Resolution of Identified Conflict of Interest: All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

Off-label or Unapproved Use of Drugs or Devices: It is the policy of the AUA to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Attendee Information and Policies

Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the American Urological Association (AUA). 

Consent to Use of Photographic Images: Registration and attendance at or participation in AUA meetings and other activities constitutes an agreement by the registrant to AUA's use and distribution (both now and in the future) of the registrant or attendee's image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video, Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the AUA.

Special Assistance/Dietary Needs: The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk.

Available Credit

  • 13.00 AMA PRA Category 1 Credit™
  • 13.00 Non-Physician Participation

Accreditation Period

Course opens: 
02/24/2018
Course expires: 
02/25/2021

Price

Price:
$1,875.00
Please login or register to take this course.